FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912092319> ?p ?o ?g. }

• W2912092319 endingPage "2930" @default.
• W2912092319 startingPage "2921" @default.
• W2912092319 abstract "Approximately 15% of all human tumors harbor mutant KRAS, a membrane-associated small GTPase and notorious oncogene. Mutations that render KRAS constitutively active will lead to uncontrolled cell growth and cancer. However, despite aggressive efforts in recent years, there are no drugs on the market that directly target KRAS and inhibit its aberrant functions. In the current work, we combined structure-based design with a battery of cell and biophysical assays to discover a novel pyrazolopyrimidine-based allosteric KRAS inhibitor that binds to activated KRAS with sub-micromolar affinity and disrupts effector binding, thereby inhibiting KRAS signaling and cancer cell growth. These results show that pyrazolopyrimidine-based compounds may represent a first-in-class allosteric noncovalent inhibitors of KRAS. Moreover, by studying two of its analogues, we identified key chemical features of the compound that interact with a set of specific residues at the switch regions of KRAS and play critical roles for its high-affinity binding and unique mode of action, thus providing a blueprint for future optimization efforts." @default.
• W2912092319 created "2019-02-21" @default.
• W2912092319 creator A5006197157 @default.
• W2912092319 creator A5007222475 @default.
• W2912092319 creator A5009852060 @default.
• W2912092319 creator A5014977539 @default.
• W2912092319 creator A5032271287 @default.
• W2912092319 creator A5037758372 @default.
• W2912092319 creator A5054637478 @default.
• W2912092319 creator A5061390911 @default.
• W2912092319 creator A5068581777 @default.
• W2912092319 creator A5087588530 @default.
• W2912092319 creator A5089872314 @default.
• W2912092319 date "2019-02-08" @default.
• W2912092319 modified "2023-10-14" @default.
• W2912092319 title "Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding" @default.
• W2912092319 cites W1482512718 @default.
• W2912092319 cites W1781036264 @default.
• W2912092319 cites W1824220821 @default.
• W2912092319 cites W1953264505 @default.
• W2912092319 cites W1960357661 @default.
• W2912092319 cites W1970102682 @default.
• W2912092319 cites W1971102429 @default.
• W2912092319 cites W1971917925 @default.
• W2912092319 cites W1973734799 @default.
• W2912092319 cites W1992947643 @default.
• W2912092319 cites W2004295816 @default.
• W2912092319 cites W2012479646 @default.
• W2912092319 cites W2022920832 @default.
• W2912092319 cites W2024839004 @default.
• W2912092319 cites W2026418335 @default.
• W2912092319 cites W2026544751 @default.
• W2912092319 cites W2027482274 @default.
• W2912092319 cites W2043282329 @default.
• W2912092319 cites W2053733865 @default.
• W2912092319 cites W2055321959 @default.
• W2912092319 cites W2069944571 @default.
• W2912092319 cites W2070210483 @default.
• W2912092319 cites W2074039305 @default.
• W2912092319 cites W2083087411 @default.
• W2912092319 cites W2088293068 @default.
• W2912092319 cites W2088562715 @default.
• W2912092319 cites W2092613403 @default.
• W2912092319 cites W2092973995 @default.
• W2912092319 cites W2115099563 @default.
• W2912092319 cites W2120829444 @default.
• W2912092319 cites W2121393047 @default.
• W2912092319 cites W2122727567 @default.
• W2912092319 cites W2127893574 @default.
• W2912092319 cites W2128339707 @default.
• W2912092319 cites W2133089242 @default.
• W2912092319 cites W2133362776 @default.
• W2912092319 cites W2134967712 @default.
• W2912092319 cites W2135184154 @default.
• W2912092319 cites W2146926552 @default.
• W2912092319 cites W2152230622 @default.
• W2912092319 cites W2152821435 @default.
• W2912092319 cites W2156194501 @default.
• W2912092319 cites W2156571424 @default.
• W2912092319 cites W2158219305 @default.
• W2912092319 cites W2158534713 @default.
• W2912092319 cites W2166262263 @default.
• W2912092319 cites W2211839632 @default.
• W2912092319 cites W2333950962 @default.
• W2912092319 cites W2548573003 @default.
• W2912092319 cites W2557331116 @default.
• W2912092319 cites W2559900897 @default.
• W2912092319 cites W2612664817 @default.
• W2912092319 cites W2767236761 @default.
• W2912092319 cites W2799702558 @default.
• W2912092319 doi "https://doi.org/10.1021/acsomega.8b03308" @default.
• W2912092319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6396121" @default.
• W2912092319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30842983" @default.
• W2912092319 hasPublicationYear "2019" @default.
• W2912092319 type Work @default.
• W2912092319 sameAs 2912092319 @default.
• W2912092319 citedByCount "62" @default.
• W2912092319 countsByYear W29120923192019 @default.
• W2912092319 countsByYear W29120923192020 @default.
• W2912092319 countsByYear W29120923192021 @default.
• W2912092319 countsByYear W29120923192022 @default.
• W2912092319 countsByYear W29120923192023 @default.
• W2912092319 crossrefType "journal-article" @default.
• W2912092319 hasAuthorship W2912092319A5006197157 @default.
• W2912092319 hasAuthorship W2912092319A5007222475 @default.
• W2912092319 hasAuthorship W2912092319A5009852060 @default.
• W2912092319 hasAuthorship W2912092319A5014977539 @default.
• W2912092319 hasAuthorship W2912092319A5032271287 @default.
• W2912092319 hasAuthorship W2912092319A5037758372 @default.
• W2912092319 hasAuthorship W2912092319A5054637478 @default.
• W2912092319 hasAuthorship W2912092319A5061390911 @default.
• W2912092319 hasAuthorship W2912092319A5068581777 @default.
• W2912092319 hasAuthorship W2912092319A5087588530 @default.
• W2912092319 hasAuthorship W2912092319A5089872314 @default.
• W2912092319 hasBestOaLocation W29120923191 @default.
• W2912092319 hasConcept C104317684 @default.
• W2912092319 hasConcept C166342909 @default.
• W2912092319 hasConcept C170493617 @default.

• next